- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02535923
CBT-I for Psychosis: Guidelines, Preliminary Efficacy, and Functional Outcomes (CBT-I)
Study Overview
Status
Intervention / Treatment
Detailed Description
The goal of this project is to develop guidelines for the clinical tailoring of Cognitive Behavioral Therapy for Insomnia (CBT-I) for Veterans with psychotic disorders and insomnia, and to test the acceptability, feasibility, and preliminary efficacy of CBT-I for improving sleep-related functional outcomes in this population.
Specific Aim 1: Develop empirically-derived guidelines for the clinical tailoring of CBT-I materials and procedures for Veterans with psychotic disorders through an iterative process with input from Veteran clients, CBT-I experts and providers, as well as those with expertise in psychotic disorders.
Specific Aim 2: Establish the acceptability of CBT-I for Veterans with psychotic disorders and insomnia when delivered using guidelines developed in Specific Aim 1 in order to make further refinements to the guidelines in a preliminary trial with 6 Veterans with psychosis and insomnia.
Specific Aim 3: Conduct a randomized controlled trial (n=60) to test the feasibility and preliminary efficacy of CBT-I in producing positive changes at post-treatment and 3-month follow-up on the outcomes of insomnia symptoms, sleep quality, and functioning.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Maryland
-
Baltimore, Maryland, United States, 21201
- Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Diagnostic and Statistical Manual of Disorders, 5th edition (DSM 5) diagnosis of schizophrenic disorders (295.0-295.9), affective psychoses (296.0-296.1, 296.4-296.8), or major depression with psychotic features (296.24, 296.34).
- Self-reported symptoms of insomnia via an Insomnia Severity Index (ISI) score of 15 or greater.
- Age between 18 and 80 as determined by medical record review.
- Participation in outpatient mental health services at a designated study site.
- Sufficient clinical stability to participate as deemed by a treatment provider.
- Capacity to sign Informed Consent.
Exclusion Criteria:
- Current problematic drug or alcohol use that impacts functioning and study engagement, as deemed by a treatment provider.
- Currently in CBT-I treatment, determined by medical records.
- Positive screen for sleep apnea via a portable sleep apnea screening device or a prior diagnosis of sleep apnea in medical records.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Cognitive Behavioral Therapy-Insomnia
CBT-I addresses cognitive, arousal and behavioral factors related to sleep difficulties.
Sessions combine assessment, conceptualization, psychoeducation, behavioral strategies and cognitive therapy, using a consistent structure including review of participants' sleep log and adherence to behavioral guidelines, modification of time in bed, cognitive therapy, and relaxation techniques.
CBT-I also incorporates psychoeducation about biological and psychological elements that regulate sleep.
Other strategies include stimulus control (i.e., getting out of bed when not sleepy) to extinguish the conditioned arousal common in insomnia, and relaxation techniques to reduce arousal associated with the bed, bedroom, or bedtime.
|
CBT-I addresses cognitive, arousal and behavioral factors related to sleep difficulties.
Sessions combine assessment, conceptualization, psychoeducation, behavioral strategies and cognitive therapy, using a consistent structure including review of participants' sleep log and adherence to behavioral guidelines, modification of time in bed, cognitive therapy, and relaxation techniques.
CBT-I also incorporates psychoeducation about biological and psychological elements that regulate sleep.
Other strategies include stimulus control (i.e., getting out of bed when not sleepy) to extinguish the conditioned arousal common in insomnia, and relaxation techniques to reduce arousal associated with the bed, bedroom, or bedtime.
|
|
Active Comparator: Health and Wellness
Health and Wellness is a general self-management curriculum focused on providing education and support for managing physical and emotional well-being.
Each session follows a basic structure including review of previous session material, new educational information and discussion on several topics over the course of single or multiple sessions.
Each session will focus on the impact of the topic on overall health and wellness, identifying benefits and challenges to improving or maintaining health in that area, and strategies that clients may find helpful to address challenges in that area.
Example topics include physical activity/exercise, nutrition/healthy eating, managing medications and side effects, and addictive behaviors (e.g., substance use, gambling, eating).
|
Health and Wellness is a general self-management curriculum focused on providing education and support for managing physical and emotional well-being.
Each session follows a basic structure including review of previous session material, new educational information and discussion on several topics over the course of single or multiple sessions.
Each session will focus on the impact of the topic on overall health and wellness, identifying benefits and challenges to improving or maintaining health in that area, and strategies that clients may find helpful to address challenges in that area.
Example topics include physical activity/exercise, nutrition/healthy eating, managing medications and side effects, and addictive behaviors (e.g., substance use, gambling, eating).
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Insomnia Severity Index (ISI)
Time Frame: Participants will be assessed following completion of the study intervention, an expected average of 10 weeks.
|
ISI score; scored on a scale of 0 to 28, with higher scores indicating worse insomnia severity.
|
Participants will be assessed following completion of the study intervention, an expected average of 10 weeks.
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Insomnia Severity Index (ISI)
Time Frame: Participants will be assessed a second time following completion of the study intervention, an expected average of 22 weeks.
|
ISI score; scored on a scale of 0 to 28, with higher scores indicating worse insomnia severity.
|
Participants will be assessed a second time following completion of the study intervention, an expected average of 22 weeks.
|
|
Veterans RAND 36-Item Health Survey Mental Component Score
Time Frame: Participants will be assessed following completion of the study intervention, an expected average of 10 weeks.
|
Veterans RAND 36-Item Health Survey score Mental Component Score; Possible scores range from 0 to 100, with higher scores indicating greater mental quality of life.
|
Participants will be assessed following completion of the study intervention, an expected average of 10 weeks.
|
|
Veterans RAND 36-Item Health Survey Mental Component Score
Time Frame: Participants will be assessed a second time following completion of the study intervention, an expected average of 22 weeks.
|
Veterans RAND 36-Item Health Survey Mental Component Score; Possible scores range from 0 to 100, with higher scores indicating greater mental health quality of life.
|
Participants will be assessed a second time following completion of the study intervention, an expected average of 22 weeks.
|
|
World Health Organization Disability Assessment Schedule (WHO-DAS), Participation in Society Subscale
Time Frame: Participants will be assessed following completion of the study intervention, an expected average of 10 weeks.
|
WHO-DAS score; scores range from 0 to 100 where 100 is full disability.
|
Participants will be assessed following completion of the study intervention, an expected average of 10 weeks.
|
|
World Health Organization Disability Assessment Schedule (WHO-DAS), Participation in Society Subscale
Time Frame: Participants will be assessed a second time following completion of study intervention, an estimated average of 22 weeks.
|
WHO-DAS score; scores range from 0 to 100 where 100 is full disability.
|
Participants will be assessed a second time following completion of study intervention, an estimated average of 22 weeks.
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Elizabeth A. Klingaman, PhD, Baltimore VA Medical Center VA Maryland Health Care System, Baltimore, MD
Publications and helpful links
General Publications
- Irwin MR, Cole JC, Nicassio PM. Comparative meta-analysis of behavioral interventions for insomnia and their efficacy in middle-aged adults and in older adults 55+ years of age. Health Psychol. 2006 Jan;25(1):3-14. doi: 10.1037/0278-6133.25.1.3.
- Cohrs S. Sleep disturbances in patients with schizophrenia : impact and effect of antipsychotics. CNS Drugs. 2008;22(11):939-62. doi: 10.2165/00023210-200822110-00004.
- Bramoweth AD, Germain A. Deployment-related insomnia in military personnel and veterans. Curr Psychiatry Rep. 2013 Oct;15(10):401. doi: 10.1007/s11920-013-0401-4.
- Klingaman EA, Palmer-Bacon J, Bennett ME, Rowland LM. Sleep Disorders Among People With Schizophrenia: Emerging Research. Curr Psychiatry Rep. 2015 Oct;17(10):79. doi: 10.1007/s11920-015-0616-7.
- Buysse DJ. Insomnia. JAMA. 2013 Feb 20;309(7):706-16. doi: 10.1001/jama.2013.193.
- Myers E, Startup H, Freeman D. Cognitive behavioural treatment of insomnia in individuals with persistent persecutory delusions: a pilot trial. J Behav Ther Exp Psychiatry. 2011 Sep;42(3):330-6. doi: 10.1016/j.jbtep.2011.02.004. Epub 2011 Mar 2.
- Dopke CA, Lehner RK, Wells AM. Cognitive-behavioral group therapy for insomnia in individuals with serious mental illnesses: a preliminary evaluation. Psychiatr Rehabil J. 2004 Winter;27(3):235-42. doi: 10.2975/27.2004.235.242.
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- D1836-W
- 1IK2RX001836-01A1 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Insomnia
-
Christoph NissenRecruitingInsomnia | Insomnia Chronic | Insomnia Disorder | Insomnia, Primary | Insomnia Type; Sleep Disorder | Insomnia Disorders | Insomnia, NonorganicSwitzerland
-
University of PennsylvaniaPatient-Centered Outcomes Research InstituteNot yet recruitingInsomnia | Chronic Insomnia | Insomnia Disorder | Chronic Insomnia DisorderUnited States
-
University of California, San FranciscoCompleted
-
VA Office of Research and DevelopmentVA Connecticut Healthcare System; US Department of Veterans AffairsCompleted
-
NYU Langone HealthNational Institute of Nursing Research (NINR); National Institutes of Health...CompletedInsomniaUnited States
-
Weill Medical College of Cornell UniversityWeill Cornell Medical College in QatarWithdrawn
-
Eisai Inc.CompletedInsomniaUnited States
-
SanofiCompletedInsomniaUnited States
-
National Yang Ming UniversityBened Biomedical Co., Ltd.Recruiting
Clinical Trials on Cognitive Behavioral Therapy-Insomnia
-
University of Kansas Medical CenterCompletedMultiple SclerosisUnited States
-
Tel Aviv UniversityIsrael Science FoundationRecruiting
-
University of ArizonaCompletedSleep Initiation and Maintenance DisordersUnited States
-
Daniel J. Taylor, Ph.D.United States Department of Defense; The University of Texas Health Science... and other collaboratorsCompletedInsomniaUnited States
-
The University of Texas Health Science Center at...Congressionally Directed Medical Research Programs; Hope Health Research InstituteRecruitingInsomnia | Mild Traumatic Brain InjuryUnited States
-
University of RochesterNational Institute of Nursing Research (NINR)CompletedDepression | Sleep | Stress Disorders, Post-TraumaticUnited States
-
Dartmouth-Hitchcock Medical CenterCrohn's and Colitis FoundationCompletedPain | Inflammation | Insomnia | Sleep Disturbance | Crohn DiseaseUnited States
-
Balearic Islands Health Service (Ibsalut)Completed
-
Oregon State UniversityMonash University; Stanford University; American Academy of Sleep MedicineCompletedSleep Initiation and Maintenance Disorders | Circadian Rhythm Sleep-Wake Disorders, Shift Work TypeUnited States